Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for simple obesity with asymptomatic hyperuricemia
ChiCTR1800015509Phase 4Recruiting
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat in hyperuricemia and obesity (2 arms), sponsored by Chengdu University of Traditional Chinese Medicine. Primary endpoints: Serum urate and Body mass index. Started Apr 2018; status: recruiting.
02
Drugs
febuxostat
03
Conditions
hyperuricemiaobesity
Beyond the preview
Go deeper on ChiCTR1800015509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015509.